FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

CareDx, Inc CDNA

Promising (early)   broader-coverage candidate · CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their

On FrontierLab's discovery record since 2026-06-15 (9 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Promising (early)" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-24), not the curated Frontier signal.
Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.

Key quality signals

Revenue growth (YoY)19.2%
Gross margin68.6%
Gross profits / assets0.69
Rule of 4016
Net margin-3.2%
Cash runway (months)
PEG
Price / sales4.7

Quality checklist

Fundamentals — snapshot as of 2026-07-24

StageEarly
Share issuance (YoY)-3.9% · buying back shares
Moat
TAM
P/E (trailing)
EPS (trailing)$-0.16
Burn multiple
Gross-margin trend (pts)1
Cash / assets0.46
Net debt / EBITDA-5
Statements as ofQ1 FY2026 · filed 2026-04-28

Momentum context — a snapshot from 2026-07-24, not current

Price at surface$37.61 (as of 2026-07-24)
52-week range$11.259 – $40.47
% off 52-wk high-7.1%
RSI (14)72
Relative volume0.7×

Risk flags

Burning cash — operating margin is negative.Parabolic one-day spike (+36%) in the last month — extreme single-day moves tend to mean-revert.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-07-24 (end-of-day). How grades are computed →